advanced search
Séverine Duband
Marketing Director, Drug Delivery Devices
Nemera

Is this your profile?

About

Séverine Duband is Marketing Director for drug delivery Devices at Nemera, steering overall category strategy, product portfolio and innovation development for five key delivery routes. She has been leading the parenteral segment at Nemera since 2018, focusing on proprietary products such as safety systems, pen injectors and on-body injectors. Ms Duband graduated from Emlyon Business School (Lyon, France) in 2004, and joined Nemera’s Global Marketing team in 2018 as a Global Category Manager, focusing on the parenteral segment.

Contributions

WEARABLES
TACKLING HIGH-VOLUME ADMINISTRATION CHALLENGES WITH A SMART, SUSTAINABLE ON-BODY INJECTOR PLATFORM
Séverine Duband introduces Symbioze, Nemera’s novel on-body injector platform device, comprising a reusable main unit and disposable prefilled drug container, and offering a balance between the need to deliver advanced formulations at high volumes and the desire for patient-centric ease-of-use that enables patients to self-administer their therapies at home.

More contributions

INJECTION
THE ADDED VALUE OF A PLATFORM APPROACH: PEN INJECTOR CASE STUDY
Radosław Romańczuk, Severine Duband and Audrey Chandra discuss the development of the company’s pen-injector platforms and how they are tailored to meet the customer’s needs.
INJECTION
LEVERAGING THE PATIENT JOURNEY TO OPTIMISE DEVICE USE AT HOME
Séverine Duband and Mark Tunkel discuss the importance of device optimisation to increase patient safety during self-administration of medication.
PREFILLED SYRINGES
INJECTION DEVICES & PAIN PERCEPTION
Severine Duband discusses the issue of patient comfort and pain perception in relation to injectable drug delivery and how the features of Nemera’s two-step autoinjector, Safelia®, help take on this challenge.
PREFILLED SYRINGES
PRODUCT REVIEW – SAFE’N’SOUND® & SAFELIA®
Séverine Duband provides a rundown of the features of Nemera’s injectable device offering, the Safe’n’Sound® single-use safety device and the Safelia® two-step autoinjector.
Top